With more than 25 years of experience, Biologics by McKesson specialty pharmacy focuses on oncology and rare diseases.
was selected by Takeda as a specialty pharmacy provider for FRUZAQLATM(fruquintinib). FRUZAQLA, approved by the U.S. Food and Drug Administration (FDA) on Nov. 8, 2023, is an oral targeted therapy for adults with metastatic colorectal cancer (...